The Italian health surveillance (SiVeAS) prioritization approach to reduce chronic disease risk factors.

International Journal of Public Health
Eduardo J SimoesEmanuele Scafato

Abstract

Because public health funds are limited, programs need to be prioritized. We used data on 15 risk factors from Italy's public health surveillance to inform prioritization of programs. We ranked risk factors using a score based on the product of six criteria: deaths attributable to risk factors; prevalence of risk factors; risk factor prevalence trend; disparity based on the ratio of risk factor prevalence between low and high education attainment; level of intervention effectiveness; and cost of the intervention. We identified seven priorities: physical inactivity; cigarette smoking (current smoking); ever told had hypertension; not having blood pressure screening; ever told had high cholesterol; alcohol (heavy drinking); not eating five fruits and vegetables a day; and not having a fecal occult blood test. This prioritization method should be used as a tool for planning and decision making.

References

Mar 31, 1977·The New England Journal of Medicine·M C Weinstein, W B Stason
Dec 1, 1992·Accident; Analysis and Prevention·L G EscobedoA A Zaidi
Jul 15, 1989·BMJ : British Medical Journal·E M Williams, M P Vessey
Nov 1, 1985·American Journal of Epidemiology·P BruzziC Schairer
Jan 1, 1994·American Journal of Public Health·E S KingP F Engstrom
Feb 1, 1996·American Journal of Public Health·R C BrownsonJ C Wilkerson
Jul 1, 1994·Journal of Medical Screening·K M TurnerF J Gilbert
May 16, 1998·American Journal of Public Health·B RockhillC Weinberg
Aug 27, 1998·Journal of Medical Screening·M J SteadM E Wheaton
Feb 29, 2000·Journal of Medical Screening·J P Sin, A S St Leger
Feb 15, 2001·American Journal of Preventive Medicine·UNKNOWN Task Force on Community Preventive Services
Feb 15, 2001·American Journal of Preventive Medicine·D P HopkinsUNKNOWN Task Force on Community Preventive Services
Mar 23, 2001·Health Technology Assessment : HTA·M RyanC M Robb
Jun 22, 2001·American Journal of Preventive Medicine·A B CoffieldA Haddix
Nov 14, 2001·Archives of Internal Medicine·D M KoffmanW A Wattigney
Nov 3, 2001·American Journal of Preventive Medicine·T B Dinh-ZarrUNKNOWN Task Force on Community Preventive Services
Nov 3, 2001·American Journal of Preventive Medicine·R A ShultsUNKNOWN Task Force on Community Preventive Services
May 3, 2002·American Journal of Preventive Medicine·Emily B KahnPhaedra Corso
Sep 5, 2002·International Journal of Health Services : Planning, Administration, Evaluation·Eeva Ollila, Meri Koivusalo
Oct 22, 2002·JAMA : the Journal of the American Medical Association·Gro Harlem Brundtland
Dec 31, 2002·JAMA : the Journal of the American Medical Association·Ali H MokdadJames S Marks
May 21, 2003·The Journal of the American Board of Family Practice·K Robin YabroffJeanne Mandelblatt
Mar 17, 2004·Preventive Medicine·Ronald E MyersNeil Schlackman
Apr 20, 2004·International Journal of Health Services : Planning, Administration, Evaluation·Joel Lexchin, Paul Grootendorst
Jun 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeanne S MandelblattMarianne Fahs
Feb 11, 2005·Journal of Studies on Alcohol·Dan ChisholmMaristela Monteiro
Mar 2, 2005·International Journal of Epidemiology·J A A DalstraJ P Mackenbach
Sep 15, 2005·Health Economics·George FranceAndrea Donatini
Feb 16, 2006·Journal of Public Health Management and Practice : JPHMP·Eduardo J SimoesAli Mokdad
Feb 24, 2006·Health Economics·Rob BaltussenMoses Aikins
Apr 19, 2006·Annals of Internal Medicine·Allen J DietrichRichard G Younge
Aug 23, 2006·Cost Effectiveness and Resource Allocation : C/E·Rob Baltussen, Louis Niessen
Dec 21, 2006·Annals of Internal Medicine·Thomas D DenbergDennis J Ahnen
May 2, 2007·Journal of Consulting and Clinical Psychology·Mary E LarimerClayton Neighbors
Oct 9, 2007·Economics and Human Biology·Cécile KnaiTim Lobstein
Jul 17, 2008·American Journal of Preventive Medicine·Roy C BaronUNKNOWN Task Force on Community Preventive Services
Jan 27, 2009·BMC Medical Research Methodology·Simon RückingerAndré Michael Toschke
Feb 25, 2009·Archives of Internal Medicine·Thomas D SequistJohn Z Ayanian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Gregory D CurfmanJeffrey M Drazen
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners
Kelly Buettner-Schmidt
© 2022 Meta ULC. All rights reserved